Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Neovasc Inc. (NVCN)

30.03   0 (0%) 04-10 16:00
Open: 29.59 Pre. Close: 30.03
High: 30.07 Low: 29.43
Volume: 1 Market Cap: 83(M)

Technical analysis

as of: 2023-05-05 4:22:22 PM
Short-term rate:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Mid-term rate:       
Target: Six months: 35.12     One year: 41.02
Support: Support1: 29.43    Support2: 29.04
Resistance: Resistance1: 30.06    Resistance2: 35.12
Pivot: 29.81
Moving Average: MA(5): 30.03     MA(20): 29.71
MA(100): 23.41     MA(250): 13.26
MACD: MACD(12,26): 0.3     Signal(9): 0.3
Stochastic oscillator: %K(14,3): 96     %D(3): 96
RSI: RSI(14): 63.9
52-week: High: 30.06  Low: 4.58
Average Vol(K): 3-Month: 28 (K)  10-Days: 1 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ NVCN ] has closed below upper band by 32.7%. Bollinger Bands are 74.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 51 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 30.1 - 30.25 30.25 - 30.37
Low: 29.61 - 29.82 29.82 - 29.98
Close: 29.74 - 30.05 30.05 - 30.3

Company Description

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Headline News

Wed, 12 Apr 2023
Neovasc : Notice of Change in Corporate Structure - Form 6-K -

Wed, 05 Apr 2023
NVCN: 3 Stocks to Evade During Earnings Season -

Fri, 31 Mar 2023
Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial ... - GlobeNewswire

Mon, 06 Mar 2023
Neovasc Shareholders Approve Acquisition by Shockwave Medical - GlobeNewswire

Wed, 01 Feb 2023
Neovasc Announces German Reimbursement Renewal - GlobeNewswire

Tue, 17 Jan 2023
Neovasc stock soars on takeover deal plus more daily small cap ... - Proactive Investors USA

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Devices
Shares Out. 3 (M)
Shares Float 0 (M)
% Held by Insiders 3.6 (%)
% Held by Institutions 7.8 (%)
Shares Short 29 (K)
Shares Short P.Month 12 (K)

Stock Financials

EPS -15.07
EPS Est Next Qtl -0.08
EPS Est This Year -0.35
EPS Est Next Year -0.21
Book Value (p.s.) 10.22
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio -2
PEG Ratio 0
Price to Book value 2.93
Price to Sales 0
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2019-07-01
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.